Meanwhile, the GnRH-ant protocol can effectively reduce the consumption of gonadotropin and greatly shorten the treatment time, and reduce the risk of ovarian hyperstimulation syndrome (OHSS) (3). The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.